TCR2 Therapeutics Inc. (TCRR)
NASDAQ: TCRR
· Real-Time Price · USD
1.48
0.00 (0.00%)
At close: May 31, 2023, 10:00 PM
TCR2 Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -163.1M | -151.82M | -119.06M | -114.71M | -107.42M | -99.81M | -90.52M | -81.2M | -73.13M |
Depreciation & Amortization | 2.96M | 3.05M | 3.15M | 3.03M | 3.02M | 2.83M | 2.45M | 2.12M | 1.8M |
Stock-Based Compensation | 8.78M | 11.38M | 11.46M | 11.95M | 12.32M | 12.27M | 11.83M | 10.71M | 9.56M |
Other Working Capital | 9.21M | 8.41M | 8.07M | 10.05M | -1.4M | 2.39M | 2.43M | 2.19M | 222K |
Other Non-Cash Items | 29.2M | 26.65M | 23.65M | 24.12M | 24.53M | 24.68M | -76K | -199K | -288K |
Deferred Income Tax | -314K | -293K | -299K | -257K | 84K | 99K | 150K | 108K | 81K |
Change in Working Capital | 12.14M | 9.58M | 4.6M | 5.81M | -2.1M | 1.62M | 4.34M | 5.19M | 1.75M |
Operating Cash Flow | -110.34M | -101.46M | -18.18M | -11.72M | -11.24M | n/a | -71.82M | -63.26M | -60.23M |
Capital Expenditures | -13.63M | -15.45M | -7.83M | -5.36M | 31K | 517K | -9.3M | -8.25M | -8.15M |
Cash Acquisitions | 15.45M | 18.53M | 3.08M | 3.08M | 3.08M | 1.8M | 8.96M | 8.96M | 8.96M |
Purchase of Investments | -132.84M | -267.52M | -225.61M | -196M | -158.38M | -50.73M | -31.4M | -130.54M | -145.59M |
Sales Maturities Of Investments | 196.5M | 194.49M | 136.49M | 101.59M | 114.32M | 140.62M | 141.75M | 135.58M | 139.71M |
Other Investing Acitivies | -14.91M | -18.53M | -15.04M | -15.04M | -15.04M | -13.77M | -8.96M | -8.96M | -8.96M |
Investing Cash Flow | 50.57M | -88.49M | -108.92M | -111.73M | -55.99M | 78.45M | 101.05M | -3.2M | -14.03M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 90K | 125K | 215K | 486K | 4.68M | 132.14M | 132.39M | 266.28M | 262.16M |
Financial Cash Flow | 90K | 125K | 215K | 486K | 4.68M | 132.14M | 132.39M | 266.28M | 262.16M |
Net Cash Flow | -59.68M | -189.82M | -208.49M | -204.57M | -144.14M | 128.98M | 161.62M | 199.82M | 187.91M |
Free Cash Flow | -123.97M | -116.91M | -26.02M | -17.08M | -11.21M | 517K | -81.12M | -71.51M | -68.38M |